P Boyer

5.4k total citations
96 papers, 3.4k citations indexed

About

P Boyer is a scholar working on Psychiatry and Mental health, Experimental and Cognitive Psychology and Pharmacology. According to data from OpenAlex, P Boyer has authored 96 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Psychiatry and Mental health, 31 papers in Experimental and Cognitive Psychology and 28 papers in Pharmacology. Recurrent topics in P Boyer's work include Treatment of Major Depression (28 papers), Schizophrenia research and treatment (22 papers) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (18 papers). P Boyer is often cited by papers focused on Treatment of Major Depression (28 papers), Schizophrenia research and treatment (22 papers) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (18 papers). P Boyer collaborates with scholars based in France, United Kingdom and United States. P Boyer's co-authors include Hervé Caci, Philippe Robert, Y. Lecrubier, Franck J. Baylé, Philippe Fossati, Gwenolé Loas, W. Rein, O. Fleurot, Jennifer L. Phillips and S. Troy and has published in prestigious journals such as American Journal of Psychiatry, Biological Psychiatry and The British Journal of Psychiatry.

In The Last Decade

P Boyer

94 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P Boyer France 30 1.4k 1.2k 836 778 594 96 3.4k
Jürgen-Christian Krieg Germany 30 815 0.6× 759 0.7× 364 0.4× 625 0.8× 815 1.4× 71 3.0k
Sakina J. Rizvi Canada 26 720 0.5× 729 0.6× 610 0.7× 651 0.8× 650 1.1× 63 2.8k
Anders Lund Norway 32 927 0.7× 630 0.5× 603 0.7× 1.0k 1.3× 246 0.4× 78 3.0k
Gabriella Juhász Hungary 38 1.3k 0.9× 696 0.6× 672 0.8× 792 1.0× 730 1.2× 163 4.1k
Shane McKie United Kingdom 35 774 0.6× 936 0.8× 609 0.7× 2.2k 2.8× 676 1.1× 87 4.0k
Nils Inge Landrø Norway 35 1.4k 1.0× 1.1k 0.9× 619 0.7× 1.5k 2.0× 1.2k 2.1× 157 4.2k
Ronald A. Remick Canada 32 1.3k 0.9× 487 0.4× 464 0.6× 355 0.5× 598 1.0× 103 3.4k
Laura Mandelli Italy 38 1.5k 1.1× 722 0.6× 625 0.7× 450 0.6× 1.5k 2.5× 126 4.7k
Edward S. Friedman United States 37 1.7k 1.2× 1.3k 1.1× 1.4k 1.7× 525 0.7× 730 1.2× 95 3.9k
Claus Normann Germany 33 795 0.6× 458 0.4× 454 0.5× 915 1.2× 441 0.7× 117 3.1k

Countries citing papers authored by P Boyer

Since Specialization
Citations

This map shows the geographic impact of P Boyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Boyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Boyer more than expected).

Fields of papers citing papers by P Boyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P Boyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Boyer. The network helps show where P Boyer may publish in the future.

Co-authorship network of co-authors of P Boyer

This figure shows the co-authorship network connecting the top 25 collaborators of P Boyer. A scholar is included among the top collaborators of P Boyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P Boyer. P Boyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hidalgo‐Mazzei, Diego, et al.. (2023). The effects of COVID-19 on European healthcare provision for working-age adults with major depressive disorder. European Psychiatry. 66(1). e39–e39. 2 indexed citations
2.
McCrone, Paul, Allan H. Young, Roland Zahn, et al.. (2023). Economic impact of reducing treatment gaps in depression. European Psychiatry. 66(1). e57–e57. 1 indexed citations
3.
Nutt, David, et al.. (2017). The value of treatment: early intervention to reduce the burden of brain disorders.. 23(4). 21–25.
4.
Frangou, Sophia, Philip Gorwood, Reinhard Heun, et al.. (2014). EPA volume 29 issue 6 Cover and Front matter. European Psychiatry. 29(6). f1–f2. 1 indexed citations
5.
Boyer, P, et al.. (2013). Efficacy and Safety of Desvenlafaxine 50 mg/d for Prevention of Relapse in Major Depressive Disorder. The Journal of Clinical Psychiatry. 74(2). 158–166. 29 indexed citations
6.
Frangou, Sophia, P Boyer, J Guelfi, et al.. (2012). EPA volume 27 issue 2 Cover and Front matter. European Psychiatry. 27(2). f1–f2. 2 indexed citations
7.
Frangou, Sophia, P Boyer, J Guelfi, et al.. (2012). EPA volume 27 issue 3 Cover and Front matter. European Psychiatry. 27(3). f1–f1. 1 indexed citations
8.
Delvecchio, Giuseppe, Philippe Fossati, P Boyer, et al.. (2011). Common and distinct neural correlates of emotional processing in Bipolar Disorder and Major Depressive Disorder: A voxel-based meta-analysis of functional magnetic resonance imaging studies. European Neuropsychopharmacology. 22(2). 100–113. 192 indexed citations
9.
Bech, Per, P Boyer, Krishna Padmanabhan, et al.. (2010). HAM-D17and HAM-D6Sensitivity to Change in Relation to Desvenlafaxine Dose and Baseline Depression Severity in Major Depressive Disorder. Pharmacopsychiatry. 43(7). 271–276. 28 indexed citations
10.
Robert, P, Chiadi U. Onyike, Albert F.G. Leentjens, et al.. (2009). Proposed diagnostic criteria for apathy in Alzheimer’s disease and other neuropsychiatric disorders. European Psychiatry. 24(2). 98–104. 445 indexed citations
11.
Boyer, P, Vincent Mahé, & David Hackett. (2004). Social adjustment in generalised anxiety disorder: a long-term placebo-controlled study of venlafaxine extended release. European Psychiatry. 19(5). 272–279. 11 indexed citations
12.
Bowden, Charles L. & P Boyer. (2003). Treatment pathways for bipolar disorder in the USA and Europe: convergence or divergence?. European Psychiatry. 18(S1). 19s–24s. 1 indexed citations
13.
Boyer, P, Vincent Mahé, D. Hackett, & V. Haudiquet. (2000). Efficacy of venlafaxine ER in social adjustment in patients with generalized anxiety disorder. European Neuropsychopharmacology. 10. 336–336. 1 indexed citations
14.
Sechter, D., et al.. (1999). A double-blind comparison of sertraline and fluoxetine in the treatment of major depressive episode in outpatients. European Psychiatry. 14(1). 41–48. 45 indexed citations
15.
Boyer, P, et al.. (1999). Amisulpride versus Amineptine and Placebo for the Treatment of Dysthymia. Neuropsychobiology. 39(1). 25–32. 85 indexed citations
16.
Brunello, N., Hagop S. Akiskal, P Boyer, et al.. (1999). Dysthymia: clinical picture, extent of overlap with chronic fatigue syndrome, neuropharmacological considerations, and new therapeutic vistas. Journal of Affective Disorders. 52(1-3). 275–290. 32 indexed citations
17.
Loas, Gwenolé, Didier Fremaux, & P Boyer. (1997). Anhedonia and Alexithymia: Distinct or Overlapping Constructs. Perceptual and Motor Skills. 84(2). 415–425. 18 indexed citations
18.
Boyer, P, et al.. (1996). Validation of the french version of PRIME-MD a primary care evaluation of mental disorder. European Neuropsychopharmacology. 6. 210–210. 6 indexed citations
19.
Loas, Gwenolé & P Boyer. (1994). [Evaluation of anhedonia in psychopathology: second study of the validation of the French version of the Chapman and Chapman physical anhedonia scale. Study of 356 persons].. PubMed. 152(4). 256–9. 14 indexed citations
20.
Boyer, P. (1981). Les troubles du langage en psychiatrie. Presses Universitaires de France eBooks. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jürgen-Christian Krieg Breakdown of academic impact, for papers by Sakina J. Rizvi Breakdown of academic impact, for papers by Anders Lund Breakdown of academic impact, for papers by Gabriella Juhász Breakdown of academic impact, for papers by Shane McKie Breakdown of academic impact, for papers by Nils Inge Landrø Breakdown of academic impact, for papers by Ronald A. Remick Breakdown of academic impact, for papers by Laura Mandelli Breakdown of academic impact, for papers by Edward S. Friedman Breakdown of academic impact, for papers by Claus Normann
Rankless by CCL
2026